117 related articles for article (PubMed ID: 10451700)
1. A somatic BRCA2 mutation in RER+ endometrial carcinomas that specifically deletes the amino-terminal transactivation domain.
Koul A; Nilbert M; Borg A
Genes Chromosomes Cancer; 1999 Mar; 24(3):207-12. PubMed ID: 10451700
[TBL] [Abstract][Full Text] [Related]
2. Causes and consequences of microsatellite instability in endometrial carcinoma.
Gurin CC; Federici MG; Kang L; Boyd J
Cancer Res; 1999 Jan; 59(2):462-6. PubMed ID: 9927063
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease. Mutations in brief no. 224. Online.
Claes K; Machackova E; De Vos M; Mortier G; De Paepe A; Messiaen L
Hum Mutat; 1999; 13(3):256. PubMed ID: 10090482
[TBL] [Abstract][Full Text] [Related]
4. BRCA2 mutations in primary breast and ovarian cancers.
Lancaster JM; Wooster R; Mangion J; Phelan CM; Cochran C; Gumbs C; Seal S; Barfoot R; Collins N; Bignell G; Patel S; Hamoudi R; Larsson C; Wiseman RW; Berchuck A; Iglehart JD; Marks JR; Ashworth A; Stratton MR; Futreal PA
Nat Genet; 1996 Jun; 13(2):238-40. PubMed ID: 8640235
[TBL] [Abstract][Full Text] [Related]
5. Ten novel BRCA1 and BRCA2 mutations in breast and/or ovarian cancer families from northern Germany.
Kiechle M; Gross E; Schwarz-Boeger U; Pfisterer J; Jonat W; Gerber WD; Albacht B; Fischer B; Schlegelberger B; Arnold N
Hum Mutat; 2000 Dec; 16(6):529-30. PubMed ID: 11102986
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the BRCA2 gene in ovarian carcinomas.
Takahashi H; Chiu HC; Bandera CA; Behbakht K; Liu PC; Couch FJ; Weber BL; LiVolsi VA; Furusato M; Rebane BA; Cardonick A; Benjamin I; Morgan MA; King SA; Mikuta JJ; Rubin SC; Boyd J
Cancer Res; 1996 Jun; 56(12):2738-41. PubMed ID: 8665505
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of BRCA1, BRCA2, and a newly identified BRCA2 exon 12 deletion variant in malignant human ovarian, prostate, and breast cancer cell lines.
Rauh-Adelmann C; Lau KM; Sabeti N; Long JP; Mok SC; Ho SM
Mol Carcinog; 2000 Aug; 28(4):236-46. PubMed ID: 10972993
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan.
Li SS; Tseng HM; Yang TP; Liu CH; Teng SJ; Huang HW; Chen LM; Kao HW; Chen JH; Tseng JN; Chen A; Hou MF; Huang TJ; Chang HT; Mok KT; Tsai JH
Hum Genet; 1999 Mar; 104(3):201-4. PubMed ID: 10323242
[TBL] [Abstract][Full Text] [Related]
9. Founder BRCA1 mutations and two novel germline BRCA2 mutations in breast and/or ovarian cancer families from North-Eastern Poland.
van Der Looij M; Wysocka B; Brozek I; Jassem J; Limon J; Olah E
Hum Mutat; 2000 May; 15(5):480-1. PubMed ID: 10790213
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations.
Khoo US; Ngan HY; Cheung AN; Chan KY; Lu J; Chan VW; Lau S; Andrulis IL; Ozcelik H
Hum Mutat; 2000 Jul; 16(1):88-9. PubMed ID: 10874312
[TBL] [Abstract][Full Text] [Related]
11. Screening for BRCA2 mutations in 81 Dutch breast-ovarian cancer families.
Peelen T; van Vliet M; Bosch A; Bignell G; Vasen HF; Klijn JG; Meijers-Heijboer H; Stratton M; van Ommen GJ; Cornelisse CJ; Devilee P
Br J Cancer; 2000 Jan; 82(1):151-6. PubMed ID: 10638982
[TBL] [Abstract][Full Text] [Related]
12. Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.
Malone KE; Daling JR; Neal C; Suter NM; O'Brien C; Cushing-Haugen K; Jonasdottir TJ; Thompson JD; Ostrander EA
Cancer; 2000 Mar; 88(6):1393-402. PubMed ID: 10717622
[TBL] [Abstract][Full Text] [Related]
13. High throughput fluorescence-based conformation-sensitive gel electrophoresis (F-CSGE) identifies six unique BRCA2 mutations and an overall low incidence of BRCA2 mutations in high-risk BRCA1-negative breast cancer families.
Ganguly T; Dhulipala R; Godmilow L; Ganguly A
Hum Genet; 1998 May; 102(5):549-56. PubMed ID: 9654203
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients.
Garvin AM; Attenhofer-Haner M; Scott RJ
J Med Genet; 1997 Dec; 34(12):990-5. PubMed ID: 9429140
[TBL] [Abstract][Full Text] [Related]
15. The Brca1 and Brca2 proteins and tumor pathogenesis.
Ingvarsson S
Anticancer Res; 1999; 19(4B):2853-61. PubMed ID: 10652564
[TBL] [Abstract][Full Text] [Related]
16. Increased frequency of TP53 mutations in BRCA1 and BRCA2 ovarian tumours.
Ramus SJ; Bobrow LG; Pharoah PD; Finnigan DS; Fishman A; Altaras M; Harrington PA; Gayther SA; Ponder BA; Friedman LS
Genes Chromosomes Cancer; 1999 Jun; 25(2):91-6. PubMed ID: 10337991
[TBL] [Abstract][Full Text] [Related]
17. Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer.
Foster KA; Harrington P; Kerr J; Russell P; DiCioccio RA; Scott IV; Jacobs I; Chenevix-Trench G; Ponder BA; Gayther SA
Cancer Res; 1996 Aug; 56(16):3622-5. PubMed ID: 8705994
[TBL] [Abstract][Full Text] [Related]
18. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes.
Vehmanen P; Friedman LS; Eerola H; McClure M; Ward B; Sarantaus L; Kainu T; Syrjäkoski K; Pyrhönen S; Kallioniemi OP; Muhonen T; Luce M; Frank TS; Nevanlinna H
Hum Mol Genet; 1997 Dec; 6(13):2309-15. PubMed ID: 9361038
[TBL] [Abstract][Full Text] [Related]
19. Multiple epithelial and nonepithelial tumors in hereditary nonpolyposis colorectal cancer: characterization of germline and somatic mutations of the MSH2 gene and heterogeneity of replication error phenotypes.
Huang RL; Chao CF; Ding DC; Yu CP; Chang CC; Lai HC; Yu MH; Liu HS; Chu TY
Cancer Genet Cytogenet; 2004 Sep; 153(2):108-14. PubMed ID: 15350299
[TBL] [Abstract][Full Text] [Related]
20. A missense mutation in the BRCA2 gene in three siblings with ovarian cancer.
Roth S; Kristo P; Auranen A; Shayehgi M; Seal S; Collins N; Barfoot R; Rahman N; Klemi PJ; Grénman S; Sarantaus L; Nevanlinna H; Butzow R; Ashworth A; Stratton MR; Aaltonen LA
Br J Cancer; 1998 Apr; 77(8):1199-202. PubMed ID: 9579822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
